COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic
NCT ID: NCT04487873
Last Updated: 2021-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
74 participants
OBSERVATIONAL
2020-07-23
2021-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Bronchiectasis on the Exacerbation and Mortality in COPD
NCT03950531
Bronchiectasis Effect in COPD Patients
NCT03670940
Comparison of Physical Activity Level Between Patients With Bronchiectasis and Healthy Subjects
NCT02550821
Effect of Expiratory Muscle Strength in Patients With Bronchiectasis
NCT07104942
Study on the Correlation Between Metabolomics and Anxiety and Depression in Bronchiectasis
NCT07291167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bronchiectasis
Having been diagnosed with non-cystic fibrosis bronchiectasis
No interventions assigned to this group
Healthy individuals
Healthy individuals without chronic disease
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No acute bronchiectasis exacerbation or infection in the past 2 weeks
* Volunteering to participate in the research
Exclusion Criteria
* Not being literate
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merve Firat
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Merve Firat, MSc
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Naciye Vardar-Yagli, PhD
Role: STUDY_DIRECTOR
Hacettepe University
Deniz İnal-İnce, Professor
Role: STUDY_CHAIR
Hacettepe University
Melda Saglam, PhD
Role: STUDY_CHAIR
Hacettepe University
Ebru Calik-Kütükcü, PhD
Role: STUDY_CHAIR
Hacettepe University
Aslıhan Cakmak, MSc
Role: STUDY_CHAIR
Hacettepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University, Faculty of Physical Therapy and Rehabilitation
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GO 20/602
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.